-
-
-
-
-
-
-
FDA approves Viatris once-weekly contraceptive patch Gwyn Lo
-
-
-
-
-
-
-
Viatris to Report First Quarter 2026 Financial Results on May 7, 2026
-
-
-
-
-
-
-
Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
-
-
-
-
-
-
-
Goldman Sachs initiates coverage on generic drugmakers, sees upside in Teva and Am
-
-
-
-
-
-
-
VTRS DEADLINE TUESDAY: BFA Law Alerts Viatris Inc. Investors of the Pending June 3 Class Action Deadline
-
-
-
-
-
-
-
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
-
-
-
-
-
-
-
VTRS SHAREHOLDER ALERT: BFA Law Reminds Viatris Inc. Investors with Losses of the Imminent June 3 Legal Deadline
-
1,231,061 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


